16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
12
Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues.
Ajinomoto
5
Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.
Ajinomoto
5
Syntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase II.
Ajinomoto
12
Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists.
Ajinomoto
15
Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids.
Ajinomoto
25
Unnatural Tripeptides as Potent Positive Allosteric Modulators of T1R2/T1R3.
Ajinomoto
16
The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Ajinomoto
27
Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Ajinomoto
27
Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.
Ajinomoto
14
Allosteric competitive inhibitors of the glucose-1-phosphate thymidylyltransferase (RmlA) from Pseudomonas aeruginosa.
University of St. Andrews
9
Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38.
The Scripps Research Institute
4
Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
University of Occupational and Environmental Health